NAT10 and cervical carcinoma: Kaplan-Meier survival analysis from the GEPIA data analysis platform showed that cervical cancer patients with high NAT10 expression had poorer Disease-free survival (DFS) compared to cervical cancer patients with low NAT10 expression, indicating that NAT10 expression was negatively associated with DFS for cervical cancer patients (Fig. 1E).